In response to the opioid overdose deaths in New York State, increased access to buprenorphine treatment for opioid overdose disorder is urgently needed. Physicians, Nurse Practitioners and Physician Assistants are welcome and highly encouraged to attend this training.
Under current regulations, authorized practitioners (MDs, DOs, NPs & PAs) are required to obtain a ‘waiver’ to prescribe buprenorphine. To acquire this waiver, physicians are required to complete a standardized buprenorphine waiver 8-hour training. Nurse Practitioners (NPs) and Physician Assistants (PAs) are required to complete the standardized buprenorphine waiver 8-hour training as well as an additional 16 hours of online training as established by the Comprehensive Addiction and Recovery Act (CARA). Residents may also take the course and apply for their waiver once they receive their DEA license. The buprenorphine waiver 8-hour training is offered in a ‘half and-half’ format [4.5 hours of in-person training followed up by 3.5 hours of online training]. Upon completion of the required training, providers will meet the requirement of the DATA 2000 to apply for a waiver to prescribe buprenorphine for opioid-dependent patients. Please contact us for further information.
Trainers: Elizabeth Loomis, MD; Michael Mendoza, MD, MPH, MS; and Holly Russell, MD, MS
CME Accreditation: The University of Rochester School of Medicine and Dentistry designates this live activity for a maximum of 4.50 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Rochester School of Medicine and Dentistry is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Funding for this course was made possible (in part) by SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does it mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. American Academy of Addiction Psychiatry is the sponsoring data organization.
The Buprenorphine Waiver Training is supported in part by Overdose Data to Action, funded by the Centers for Disease Control and Prevention.
